Soluble BCMA CAR Sandwich ELISA Kit for Multiple Myeloma CAR-T Monitoring

The Soluble BCMA CAR Sandwich ELISA Kit quantitatively measures the extracellular domain of BCMA-specific CAR shed into human serum, plasma and culture supernatant. It supports exposure and persistence monitoring of BCMA CAR-T therapy in multiple myeloma.

Order information

Catalog No.Product NameKit SizePrice (In USD)Plate format
GMV-LVc-BCMA-ELISA-1Soluble BCMA CAR Sandwich ELISA Kit96T96-well, 12 × 8 removable strips, pre-coated and ready to use

Description

Analyte / TargetSoluble BCMA CAR (CAR ectodomain shed from anti-BCMA scFv CAR)
Species ReactivityHuman
Assay TypeQuantitative sandwich ELISA (capture anti-CAR mAb + biotinylated target antigen)
Detection MethodColorimetric, TMB substrate; absorbance read on a standard microplate reader
Sample TypeHuman serum, plasma (EDTA / heparin) and cell culture supernatant
Kit Components96-well strip plate pre-coated with anti-CAR capture mAb; lyophilized recombinant target-antigen standard; biotinylated target antigen (detection); streptavidin-HRP; sample diluent; concentrated wash buffer; TMB substrate; stop solution; plate sealer
Plate Format96-well, 12 × 8 removable strips, pre-coated and ready to use
Assay WorkflowSingle-day bench workflow: sample / standard incubation, wash, biotinylated antigen, streptavidin-HRP, TMB substrate and stop. Compatible with standard manual and automated microplate washers.
PerformanceA broad quantitative working range is covered by an eight-point standard curve with 4-PL data reduction, and the assay is tuned to the levels of shed CAR typically found in serum, plasma and culture supernatant. Reproducibility within and between runs is carefully controlled, spike recovery in serum, plasma and culture medium is acceptable, and samples behave linearly on dilution, so concentrated samples can be diluted into the working range with confidence. Detailed performance data are documented per lot in the Certificate of Analysis.
SpecificityRecognizes the BCMA-binding ectodomain of BCMA CAR; no cross-reactivity with human IgG / Fc, recombinant BCMA, or CARs of unrelated specificity (CD19, CD20, HER2, GPC3).
Storage & StabilityStore at 2–8 °C; the coated plate must not be frozen. Kit reagents are stable until the expiry date printed on the label.
ApplicationQuantification of soluble BCMA CAR in patient serum / plasma for myeloma CAR-T PK-PD; supernatant CAR expression QC.
Products descriptionBCMA (TNFRSF17) is expressed almost exclusively on plasma cells and is the leading validated target for multiple myeloma CAR-T therapy. Serum BCMA itself is a well-recognized disease biomarker, and soluble BCMA CAR adds a direct measure of CAR-T exposure in the same sample matrix. The kit captures soluble BCMA CAR with an anti-CAR antibody and detects it with biotinylated BCMA antigen, providing an antigen-competent readout. Applications include PK-PD sampling in myeloma trials, correlation with M-protein and serum BCMA responses, and CAR expression QC in manufacturing supernatants.



<